Saturday, July 12, 2025
Khmer Daily Cambodia News
34 °c
Phnom Penh
  • LATEST
  • CAMBODIA
  • ASIA
    • JAPAN
    • SOUTH KOREA
    • TAIWAN
  • WORLD
    • CHINA
    • RUSSIA
  • BUSINESS CAMBODIA
  • TECHNOLOGY
No Result
View All Result
  • LATEST
  • CAMBODIA
  • ASIA
    • JAPAN
    • SOUTH KOREA
    • TAIWAN
  • WORLD
    • CHINA
    • RUSSIA
  • BUSINESS CAMBODIA
  • TECHNOLOGY
No Result
View All Result
The Khmer Daily
No Result
View All Result
Home World

J&J pauses Covid-19 vaccine trials due to unexplained illness in participant

October 15, 2020
in World
0
J&J pauses Covid-19 vaccine trials due to unexplained illness in participant
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Johnson & Johnson said on Monday it had temporarily paused its Covid-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest profile efforts to contain the global pandemic.

The participant’s illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company’s clinical and safety physicians, the company said here in a statement.

J&J, which reports quarterly financial results on Tuesday morning, said that such pauses are normal in big trials, which can include tens of thousands of people. It said the “study pause” in giving doses of the vaccine candidate was different from a “regulatory hold” required by health authorities. The current case is a pause.

However, J&J’s move follows a similar one by AstraZeneca Plc. In September, AstraZeneca paused late-stage trials of its experimental coronavirus vaccine, developed with the University of Oxford, due to an unexplained illness in a UK study participant.

While trials in the UK, Brazil, South Africa and India have resumed, the US trial is still on hold pending a regulatory review.

Dr. William Schaffner, a professor of infectious diseases at the Vanderbilt University School of Medicine, said by email that “Everybody is on the alert because of what happened with AstraZeneca,” adding that it could take a week to gather information.

“It would have to be a serious adverse event. If it was something like prostate cancer, uncontrolled diabetes or a heart attack – they wouldn’t stop it for any of those reasons. This is likely to be a neurological event,” he said.

Last month, J&J said its experimental Covid-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, following which the company kicked off a final 60,000-person trial, whose results had been expected by the end of this year or early 2021.

Johnson & Johnson declined to elaborate about the illness due to privacy concerns. It did say that some participants in studies get placebos, and it was not always clear whether a person suffering a serious adverse event in a clinical trial received a placebo or the treatment.

Stat News reported here the pause earlier in the day citing a document sent to outside researchers, which stated that a “pausing rule” had been met, the online system used to enroll patients in the study had been closed and the data and safety monitoring board would be convened.

This article was first published in Asia One . All contents and images are copyright to their respective owners and sources.

Tags: #clinical trials#coronavirus#COVID-19#Johnson & Johnson#Vaccinesshow all tags
Previous Post

Cambodia​ and China signed a free trade agreement in Phnom Penh

Next Post

Smart Axiata piloted Internet of Things challenge to boost digital innovations in Cambodia

Related Posts

Italy to pass ‘right to be forgotten’ law for cancer survivors

Italy to pass ‘right to be forgotten’ law for cancer survivors

by AsiaOne
June 15, 2023
0
25

ROME — Italy will pass a law on the "right to be forgotten" (RTBF) for cancer survivors, Prime Minister Giorgia Meloni...

Bill Gates in China: Microsoft co-founder to meet Xi Jinping

Bill Gates in China: Microsoft co-founder to meet Xi Jinping

by AsiaOne
June 15, 2023
0
40

HONG KONG — Bill Gates, Microsoft Corp's co-founder, is set to meet Chinese President Xi Jinping on Friday (June 16) during his...

US judge temporarily blocks Microsoft acquisition of Activision

US judge temporarily blocks Microsoft acquisition of Activision

by AsiaOne
June 15, 2023
0
31

WASHINGTON - A US judge late on Tuesday (June 13) granted the Federal Trade Commission's (FTC) request to temporarily block Microsoft...

Most Popular

New dairy farm in Cambodia, Kirisu, goes into fresh milk production operated by Khmer Fresh Milk

New dairy farm in Cambodia, Kirisu, goes into fresh milk production operated by Khmer Fresh Milk

July 17, 2020
507
Neak Poan Temple is a destination for tourists to visit and take beautiful pictures

Neak Poan Temple is a destination for tourists to visit and take beautiful pictures

July 3, 2023
107

$140 million brewery factory in Cambodia, Vattanac Brewery, will employ 1,500

June 27, 2020
118
Ezecom, ISP in Cambodia, 14 years of operations to bring World-Class Digital Service for Cambodians

Ezecom, ISP in Cambodia, 14 years of operations to bring World-Class Digital Service for Cambodians

March 26, 2022
28
Is this Japan’s weirdest mascot? Meet Hokkaido’s Zushihocky, part rice, part clam

Is this Japan’s weirdest mascot? Meet Hokkaido’s Zushihocky, part rice, part clam

May 27, 2020
38
Cambodia rice production losses caused by droughts about $100 million

Cambodia rice production losses caused by droughts about $100 million

October 1, 2021
16

© 2020 By Khmer Daily News

No Result
View All Result
  • Home
  • Latest
  • Cambodia
  • ASIA
  • World
  • Business
  • Tech

© 2019 The Khmer Daily.

error: Content is protected !!